GAMMA Investing’s Zymeworks ZYME Stock Holding History

GAMMA Investing’s Portfolio ZYME Stock Details ZYME Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q3	$31.2K	Buy	1,176 +62	+6%	+$1.61K	﹤0.01%	2666
2026 Q2	$29.1K	Buy	1,114 +17	+2%	+$432	﹤0.01%	2632
2026 Q1	$27.5K	Buy	1,097 +112	+11%	+$2.65K	﹤0.01%	2546
2025 Q4	$25.9K	Buy	985 +180	+22%	+$3.93K	﹤0.01%	2470
2025 Q3	$13.7K	Sell	805 -5	-0.6%	-$72	﹤0.01%	2714
2025 Q2	$10.2K	Buy	810 +267	+49%	+$3.18K	﹤0.01%	2796
2025 Q1	$6.47K	Buy	543 +10	+2%	+$136	﹤0.01%	2965
2024 Q4	$7.8K	Buy	533 +100	+23%	+$1.4K	﹤0.01%	2731
2024 Q3	$5.43K	Buy	433 +321	+287%	+$3.5K	﹤0.01%	2715
2024 Q2	$953	Sell	112 -45	-29%	-$401	﹤0.01%	3068
2024 Q1	$1.65K	Buy	157 +100	+175%	+$1.11K	﹤0.01%	2802
2023 Q4	$618	Buy	+57	New	+$454	﹤0.01%	2916

Other funds holding ZYME

VCM

Versant Capital Management Phoenix, Arizona $1.17B AUM 28.44% 1-Year Est. Return

FFA

Farther Finance Advisors San Francisco, California $14.2B AUM 18.33% 1-Year Est. Return

GAMMA Investing's ZYME Position: Q3 2026 in Review

GAMMA Investing increased its Zymeworks (ZYME) stake by 5.6% in Q3 2026, buying an estimated $1.61K and bringing the position to 1,176 shares worth $31.2K. The position accounts for ﹤0.01% of the portfolio, ranked #2666.

GAMMA Investing first reported a position in ZYME in Q4 2023 and has held it in 12 quarters since. 3 funds tracked by Wall St. Rank hold ZYME as of Q3 2026.

GAMMA Investing held 1,176 shares of Zymeworks worth $31.2K as of Q3 2026.
GAMMA Investing bought 62 Zymeworks shares in Q3 2026, an estimated $1.61K.
Zymeworks made up ﹤0.01% of GAMMA Investing's portfolio in Q3 2026, its #2666 holding.
GAMMA Investing first reported a position in Zymeworks in Q4 2023 and has held it in 12 quarters since.
3 funds tracked by Wall St. Rank held Zymeworks as of Q3 2026.

Based on GAMMA Investing's 13F filing for Q3 2026, filed 8 Oct 2026.